Eveready Inds. Q4 FY26 Earnings Analysis
Published 17 Aug 2026 | Household Products | Market Cap: ₹2.6K Cr
Price
₹356
Market Cap
₹2.6K Cr
P/E Ratio
16.3
Earnings Summary
Alkaline battery volumes expected to double, growing at over 20% CAGR, becoming 1/3 of the overall battery segment in India over 5-10 years (Page 6, 12, 13). FY '26 saw revenue growth of 8.2% and EBITDA growth of 8.9%, with an 11.5% EBITDA margin.
📊 Revenue & Sales Performance
- →Alkaline battery volumes expected to double, growing at over 20% CAGR, becoming 1/3 of the overall battery segment in India over 5-10 years (Page 6, 12, 13).
- →Zinc battery volumes expected to remain flat or grow low single digits; some cannibalization by alkaline segment anticipated (Page 12, 13).
- →Flashlight and lighting segment showed steady growth (~3% to 8.1%) with focus on premium/rechargeable products; expected to contribute about 12%-23% of total mix; growth sustained and considered sustainable (Page 4, 10, 13).
- →Jammu alkaline battery plant to ramp up to ~30% utilization by year-end, producing 100+ million units in first year, supporting growth, margins, and market share (Page 4, 5, 6).
- →Adjacent categories like mosquito racquets, power banks, and chargers expected to expand (Page 4).
- →Overall volume drivers remain alkaline batteries and premiumization across categories (Page 13).
- →FY '27 seen as an important year of optimization with growth acceleration (Page 4).
📈 Profitability & Margins
- →FY '26 saw revenue growth of 8.2% and EBITDA growth of 8.9%, with an 11.5% EBITDA margin.
- →FY '27 expected as a year of optimization with Jammu plant ramp-up, stronger alkaline battery penetration, and premiumization.
- →The alkaline battery segment is growing at 20%+ CAGR and is expected to become one-third of the battery market in 5-10 years.
- →Breakeven for the Jammu plant's payback expected in 5-6 years; operational breakeven potentially from year 1 due to scale.
- →The company aims to maintain EBITDA margins similar to FY '26 (~11.5%) despite commodity cost volatility.
- →Debt reduction remains a priority to improve financial flexibility, supporting strategic growth and margin expansion.
- →Expansion in adjacencies like mosquito racquets and power banks expected to aid earnings.
- →Overall, management is confident about sustainable growth, margin discipline, and long-term value creation.
🏗️ Capital Expenditure Plans
💰 Fundraising & Capital Structure
- →The company does not anticipate any additional capital expenditure beyond routine capex in the near term.
- →They have already received INR44 crores advance for Plot B2 and expect to receive the balance INR90+ crores in the current year.
- →Proceeds from the sale of Plot B (Noida land transactions) amounting to a total of INR251 crores will be primarily utilized for debt reduction.
- →The management's first preference with these proceeds is to reduce borrowings significantly.
- →The company has a clear objective to continue debt reduction; they reduced debt by more than INR100 crores in the current fiscal year and aim to further reduce debt in FY '27.
- →No mentions of new fundraising through equity were noted in this call or document excerpts.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Eveready Inds. Q4 FY26 results?
Alkaline battery volumes expected to double, growing at over 20% CAGR, becoming 1/3 of the overall battery segment in India over 5-10 years (Page 6, 12, 13). FY '26 saw revenue growth of 8.2% and EBITDA growth of 8.9%, with an 11.5% EBITDA margin.
What is Eveready Inds. share price analysis?
Eveready Inds. currently shows a neutral. The stock trades at a P/E of 16.3 with a market cap of ₹2,591 Cr. Investors should review the full earnings analysis for detailed insights.
Is Eveready Inds. planning capital expenditure?
The Jammu facility, which is the only alkaline battery plant in India, was commissioned recently with commercial production starting shortly; it supports manufacturing of alkaline batteries, zinc batteries, flashlights, and lighting products.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.